The clinical presentation of systemic sclerosis (SSc) differs significantly between adult and pediatric patients, according to a recent study in…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
FT011, a treatment candidate from Certa Therapeutics, was safe and led to clinically meaningful improvements for more than…
Elevations in two indices of body-wide inflammation are associated with greater disease activity in systemic sclerosis (SSc) patients, according…
Systemic sclerosis (SSc) patients with interstitial lung disease (ILD) were more likely to have a diffuse cutaneous (dcSSc)…
A new study has found that defects in centromeres — specific regions of chromosomes — are evident in skin cells…
Blood levels of the periostin protein were associated with the degree of skin and cardiac involvement, but not lung or…
The levels of a small RNA molecule called microRNA-27a, or miR-27a, are significantly lower in the blood of women with…
Tobacco use by systemic sclerosis (SSc) patients is linked to worsening gastrointestinal (GI) symptoms, but the immunosuppressive and…
People with systemic sclerosis (SSc) have lower-than-normal levels of the SPAG17 protein in their skin cells, which contributes to…
Levels of a protein called soluble suppression of tumorigenicity-2 (sST2) were linked to signs of cardiac involvement in people with…